Mark C Healey
Veterinary in Logan, UT
License number
Utah 113528-2801
Issued Date
Sep 3, 1982
Expiration Date
Sep 30, 2004
Category
Veterinarian
Type
Veterinarian
Address
Address
Logan, UT
Personal information
See more information about Mark C Healey at radaris.comName
Address
Phone
578 E 1200 N, Logan, UT 84341
Professional information
See more information about Mark C Healey at trustoria.com
Bacterial Extract Vaccines For Veterinary Application
Bacterial Extract Vaccines For Veterinary Application
US Patent:
4981685, Jan 1, 1991
Filed:
Sep 17, 1987
Appl. No.:
7/098773
Inventors:
Mark C. Healey - Logan UT
Assignee:
Utah State University Foundation - Logan UT
International Classification:
A61K 3702, A61K 3739
US Classification:
424 92
Abstract:
The present invention relates to novel bacterial extract vaccines for use in veterinary medicine and to novel methods for preparing such vaccines. The bacteria responsible for a particular bacterially induced disease is contacted with a detergent so as to extract from the bacterial cells the antigens responsible for eliciting a protective immune response against the disease. Subsequently, the resultant antigen extract is dialyzed to remove the detergent. The antigen extract is then preferably combined with a vaccine enhancing adjuvant to provide an effective and inexpensive vaccine for veterinary application. The present invention provides for the preparation of a variety of vaccines which can be used to immunize animals against a variety of bacterially induced diseases.
Method Of Controlling Cryptosporidium Infectons Using Protease Inhibitors
Method Of Controlling Cryptosporidium Infectons Using Protease Inhibitors
US Patent:
5750496, May 12, 1998
Filed:
Aug 12, 1996
Appl. No.:
8/695411
Inventors:
John R. Forney - Logan UT
Shiguang Yang - Logan UT
Mark C. Healey - Logan UT
Shiguang Yang - Logan UT
Mark C. Healey - Logan UT
Assignee:
Utah State University - Logan UT
International Classification:
A01N 3718, A01N 4500, A61K 3800, A61K 3156
US Classification:
514 2
Abstract:
A method for controlling infections caused by Cryptosporidium parvum. The method comprises using protease inhibiting compounds, preferably serine protease inhibitors, to inhibit excystation, invasion, and parasite maturation and development. The method is directed to therapeutic treatment of mammals, such as humans, exposed to C. parvum, and additionally as a prophylactic treatment in immunocompromised subjects at high risk for contracting cryptosporidiosis.
Method Of Controlling Protozoan Infections Using Syringomycin-Family Lipodepsipeptides
Method Of Controlling Protozoan Infections Using Syringomycin-Family Lipodepsipeptides
US Patent:
6310037, Oct 30, 2001
Filed:
Apr 26, 1999
Appl. No.:
9/299266
Inventors:
Jon Y. Takemoto - North Logan UT
John R. Forney - Wrair Washington DC
Mark C. Healey - Utah State University UT
Shiguang Yang - Logan UT
Karl A. Werbovetz - Montgomery Village MD
John R. Forney - Wrair Washington DC
Mark C. Healey - Utah State University UT
Shiguang Yang - Logan UT
Karl A. Werbovetz - Montgomery Village MD
Assignee:
Utah State University - Logan UT
International Classification:
A01N 3718, A61K 3800
US Classification:
514 2
Abstract:
A method for controlling infections caused by protozoans, such as Cryptosporidium parvum, Plasmodium falciparum, and Leishmania donovani. The method comprises using syringomycin-family lipodepsipeptides, preferably syringomycins such as syringomycin E, to control or prevent infections caused by protozoans. The method is directed to therapeutic treatment of mammals, such as humans, exposed to protozoans, and additionally as a prophylactic treatment in immunocompromised subjects at high risk for contracting protozoan infections.